Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.verified

HOWL

Price:

$2.48

Market Cap:

$108.38M

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company...[Read more]

Industry

Biotechnology

IPO Date

2021-04-30

Stock Exchange

NASDAQ

Ticker

HOWL

The Current Ratio as of November 2024 (TTM) for Werewolf Therapeutics, Inc. (HOWL) is 12.13

According to Werewolf Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 12.13. This represents a change of -39.44% compared to the average of 20.03 of the last 4 quarters.

Werewolf Therapeutics, Inc. (HOWL) Historical Current Ratio (quarterly & annually)

How has HOWL Current Ratio performed in the past?

The mean historical Current Ratio of Werewolf Therapeutics, Inc. over the last ten years is 10.59. The current 12.13 Current Ratio has changed 11.35% with respect to the historical average. Over the past ten years (40 quarters), HOWL's Current Ratio was at its highest in in the September 2023 quarter at 54.15. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

10.59

Median

8.84

Minimum

5.84

Maximum

17.58

Werewolf Therapeutics, Inc. (HOWL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Werewolf Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 98.98%

Maximum Annual Current Ratio = 17.58

Minimum Annual Increase = -56.92%

Minimum Annual Current Ratio = 5.84

Quarterly (TTM)
Annual
YearCurrent RatioChange
20237.1422.18%
20225.84-56.92%
202113.56-22.86%
202017.5898.98%

Werewolf Therapeutics, Inc. (HOWL) Average Current Ratio

How has HOWL Current Ratio performed in the past?

The current Current Ratio of Werewolf Therapeutics, Inc. (HOWL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

8.85

5-year avg

10.59

10-year avg

10.59

Werewolf Therapeutics, Inc. (HOWL) Current Ratio vs. Peers

How is HOWL’s Current Ratio compared to its peers?

Werewolf Therapeutics, Inc.’s Current Ratio is greater than Monte Rosa Therapeutics, Inc. (6.56), less than Design Therapeutics, Inc. (41.42), less than Ikena Oncology, Inc. (18.22), greater than Stoke Therapeutics, Inc. (6.67), less than Edgewise Therapeutics, Inc. (30.24), greater than Decibel Therapeutics, Inc. (3.03), less than Celcuity Inc. (14.95), greater than C4 Therapeutics, Inc. (6.31), less than Talaris Therapeutics, Inc. (18.64), less than Adicet Bio, Inc. (12.75), less than Cullinan Oncology, Inc. (28.87), greater than Vor Biopharma Inc. (6.54), less than Third Harmonic Bio, Inc. (41.13), greater than Passage Bio, Inc. (7.67), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Eliem Therapeutics, Inc. (60.41), less than Molecular Partners AG (14.58), less than MediciNova, Inc. (18.24), less than Anebulo Pharmaceuticals, Inc. (13.46), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89),

Build a custom stock screener for Werewolf Therapeutics, Inc. (HOWL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Werewolf Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Werewolf Therapeutics, Inc. (HOWL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Werewolf Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Werewolf Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Werewolf Therapeutics, Inc. (HOWL)?

What is the highest Current Ratio for Werewolf Therapeutics, Inc. (HOWL)?

What is the 3-year average Current Ratio for Werewolf Therapeutics, Inc. (HOWL)?

What is the 5-year average Current Ratio for Werewolf Therapeutics, Inc. (HOWL)?

How does the current Current Ratio for Werewolf Therapeutics, Inc. (HOWL) compare to its historical average?